pGM169/GL67A
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Imperial College London
Overview
pGM169/GL67A is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
pGM169/GL67A clinical trials
Explore related
Medical disclaimer. This page summarizes research about pGM169/GL67A for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.